Tirzepatide

Tirzepatide is a synthetic peptide designed as a dual agonist of both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual-incretin mechanism has made it a subject of growing interest in metabolic and endocrine research. By activating both GIP and GLP-1 signaling pathways, Tirzepatide is studied for its potential influence on insulin secretion, glucose regulation, and appetite control. Research suggests that this dual receptor activity may provide complementary metabolic effects by integrating multiple hormonal pathways involved in nutrient metabolism and energy balance. Scientific investigations have examined Tirzepatide’s impact on gastric motility, pancreatic signaling, adipose-tissue metabolism, and central appetite…